Sappi, UPM offer remedies in bid for EU antitrust approval for paper joint venture
Sappi, UPM offer remedies in bid for EU antitrust approval for paper joint venture BRUSSELS, Nov 5 (Reuters) - Finland's UPM-Kymmene UPM.HE and South Africa-listed Sappi SAP.J on Thursday offered remedies in an effort to secure EU antitrust approval for their €1.42 billion ($1.6 billion) paper joint venture, the companies said on Thursday.
The remedies 'include capacity optimisation for the supply of certain paper grades in Europe' and 'certain commercial safeguards for customers, and investments in decarbonisation, electrification and energy efficiency', they said.
($1 = 0.8880 euros)
(Reporting by Foo Yun Chee and Sudip Kar-Gupta; editing by Philip Blenkinsop)
((foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net/))
Recent news on UPM-Kymmene Oyj
See all newsBrief: UPM Says No Casualties In Pietarsaari Fire
Sappi, UPM offer remedies to win EU antitrust approval for paper joint venture (updated)
Sappi, UPM offer remedies in bid for EU antitrust approval for paper joint venture
Brief: UPM And Sappi Submit Remedies In European Commission Review Of Proposed Graphic Paper Joint Venture
Europe Research Roundup: Centrica, Fuchs, URW